Mary Coleman
Investor Relations Contact bij CATALYST PHARMACEUTICALS, INC.
Actieve functies van Mary Coleman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Investor Relations Contact | 16-08-2021 | - |
Loopbaan van Mary Coleman
Eerdere bekende functies van Mary Coleman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| AGILE THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Investor Relations Contact | 01-01-2018 | - |
| Public Communications Contact | 01-01-2018 | - | |
| SAVIENT PHARMACEUTICALS INC | Investor Relations Contact | - | - |
| Public Communications Contact | 31-08-2010 | - |
Opleiding van Mary Coleman
| Bowling Green State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Investor Relations Contact | 5 |
| Public Communications Contact | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Beurs
- Insiders
- Mary Coleman
- Ervaring
